Bleakley Financial Group, LLC
Position in PTGX — Protagonist Therapeutics, Inc
CIK 1936953
PARSIPPANY, NJ
Position in PTGX
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$1,349,330
+$1,103,564 QoQ
Shares Held
12,802
+101.1% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
4 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Bleakley Financial Group, LLC holds $16,625,065 across 16 Biotechnology names. PTGX ranks #3 (8.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
17,226 | $7,692,098 | |
| 2 | ANAB |
Anaptysbio, Inc
|
43,120 | $1,594,288 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
This page
|
12,802 | $1,349,330 | |
| 4 | IBRX |
ImmunityBio, Inc.
|
163,572 | $1,254,597 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
14,316 | $1,074,988 | |
| 6 | BCAX |
Bicara Therapeutics Inc.
|
29,331 | $583,393 | |
| 7 | RPRX |
Royalty Pharma plc
|
10,967 | $526,086 | |
| 8 | TGTX |
Tg Therapeutics, Inc.
|
11,628 | $386,282 |
All Filings in PTGX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,349,330 | 12,802 | Shares | Sole | 2026-05-04 | |
| 2024-12-31 | $245,766 | 6,367 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $316,395 | 7,031 | Shares | Sole | 2024-10-16 | |
| 2023-09-30 | $173,655 | 10,411 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||